Researchers use skin-colonizing bacteria to create a topical cancer therapy in mice, News Center

In a study led by Stanford Medicine, researchers harnessed the skin’s immune response to bacteria to create an immunotherapy — delivered by swab — that treats aggressive tumors in mice.

Neutrophil-like Biomimic AIE Nanoparticles with High-Efficiency Inflammatory Cytokine Targeting Enable Precise Photothermal Therapy and Alleviation of Inflammation

Role of the gut microbiota in anticancer therapy: from molecular mechanisms to clinical applications

Frontiers The Skin and Intestinal Microbiota and Their Specific Innate Immune Systems

Recent advances in single-cell engineered live biotherapeutic products research for skin repair and disease treatment

Emulating interactions between microorganisms and tumor microenvironment to develop cancer theranostics

Frontiers Secreted Toxins From Staphylococcus aureus Strains Isolated From Keratinocyte Skin Cancers Mediate Pro-tumorigenic Inflammatory Responses in the Skin

The human skin microbiome Nature Reviews Microbiology

New research paper supports using microbiome data to develop potential probiotic therapies - International Society of Microbiota

Development of a human skin commensal microbe for bacteriotherapy of atopic dermatitis and use in a phase 1 randomized clinical trial

Frontiers Skin Microbiome and Treatment-Related Skin Toxicities in Patients With Cancer: A Mini-Review

Bacterial therapies at the interface of synthetic biology and nanomedicine

Skin bacteria may be an answer to cancer find researchers

Antibiotics, Free Full-Text

Immune checkpoint inhibitors unleash pathogenic immune responses against the microbiota

Researchers Use Skin Bacteria as Topical Cancer Therapy